Production of recombinant coagulation factors: Are humans the best host cells?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Production of recombinant coagulation factors: Are humans the best host cells?

Published:2017-02-23 Issue:5 Volume:8 Page:462-470
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Swiech Kamilla¹²^ORCID,Picanço-Castro Virgínia²,Covas Dimas Tadeu²³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil

2. Center for Cell-based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil

3. Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2017.1279767

Reference58 articles.

1. The past and future of haemophilia: diagnosis, treatments, and its complications

2. An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier

3. Production of High-Potency Concentrates of Antihemophilic Globulin in a Closed-Bag System

4. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma

5. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emicizumab as a Promising Form of Therapy for Type A Hemophilia - AReview of Current Knowledge from Clinical Trials;Current Protein & Peptide Science;2024-11

2. Formulations with Active Plant Molecules and Additional Therapies in Wound Healing;Revista Brasileira de Farmacognosia;2024-09-13

3. Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab;TH Open;2024-04

4. A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics;American Journal of Health-System Pharmacy;2024-02-13

5. Advances and challenges in the purification of recombinant coagulation factors: A review;Journal of Chromatography A;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3